Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Radicicol
Cat. No.:
OB0425LY-383
Appearance:
Solid
Purity:
99.63%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Radicicol is an inhibitor of fat mass and obesity-associated protein (FTO) with antifungal and antimalarial effects.
Synonyms:
12772-57-5; (+)-Monorden A; Monorderne; Radicolol; Radisicol; (1aR,2Z,4E,14R,15aR)-8-Chloro-9,11-dihydroxy-14-methyl-1a,14,15,15a-tetrahydro-6H-oxireno[e][2]benzoxacyclotetradecine-6,12(7H)-dione
CAS No.:
12772-57-5
Compound CID:
6323491
Formula:
C18H17ClO6
Formula Weight:
364.78
Specification
Target:
HSP; Bacterial; Antibiotic; Parasite
Pathway:
Cell cycle/DNA damage; Metabolic enzyme/Protease; Anti-infection
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
Radicicol is involved in obesity research could also be used in the development of novel fat inhibitors.
